Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

BACKGROUND: Honokiol is a major bioactive compound extracted from Magnolia. The present study was designed to determine whether liposomal honokiol has the antitumor activity against human lung cancer as well as potentiates the antitumor activity of cisplatin in A549 lung cancer xenograft model, if s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qi-qi, Fan, Lin-yu, Yang, Guang-li, Guo, Wen-Hao, Hou, Wen-li, Chen, Li-juan, Wei, Yu-quan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543046/
https://www.ncbi.nlm.nih.gov/pubmed/18706101
http://dx.doi.org/10.1186/1471-2407-8-242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543046/
https://www.ncbi.nlm.nih.gov/pubmed/18706101
http://dx.doi.org/10.1186/1471-2407-8-242

Ejemplares similares